Survivin-T34A: molecular mechanism and therapeutic potential

References

• DeverauxQLReedJCIAP family proteins – suppressors of apoptosisGenes Dev19991332392529990849
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
   PubMed Web of Science ®Google Scholar
• VelculescuVEMaddenSLZhangLAnalysis of human transcriptomesNat Genet199923438738810581018
   PubMed Web of Science ®Google Scholar
• ReedJCThe survivin saga goes in vivoJ Clin Invest2001108796596911581297
   PubMed Web of Science ®Google Scholar
• LiFAmbrosiniGChuEYControl of apoptosis and mitotic spindle checkpoint by survivinNature199839667115805849859993
   PubMed Web of Science ®Google Scholar
• LiFSurvivin study: what is the next wave?J Cell Physiol2003197182912942537
   PubMed Web of Science ®Google Scholar
• AndersenMHSvaneIMBeckerJCStratenPTThe universal character of the tumor-associated antigen survivinClin Cancer Res200713205991599417947459
   PubMed Web of Science ®Google Scholar
• KhanSAspeJRAsumenMGExtracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potentialBr J Cancer200910071073108619293795
   PubMed Web of Science ®Google Scholar
• KhanSJutzyJMAspeJRMcGregorDWNeidighJWWallNRSurvivin is released from cancer cells via exosomesApoptosis2010818 [Epub ahead of print]
   Web of Science ®Google Scholar
• O’ConnorDSGrossmanDPlesciaJRegulation of apoptosis at cell division by p34cdc2 phosphorylation of survivinProc Natl Acad Sci U S A20009724131031310711069302
   PubMed Web of Science ®Google Scholar
• MesriMWallNRLiJKimRWAltieriDCCancer gene therapy using a survivin mutant adenovirusJ Clin Invest2001108798199011581299
   PubMed Web of Science ®Google Scholar
• WallNRO’ConnorDSPlesciaJPommierYAltieriDCSuppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosisCancer Res200363123023512517802
   PubMed Web of Science ®Google Scholar
• ZhouSLiLJianXThe phosphorylation of survivin Thr34 by p34cdc2 in carcinogenesis of oral submucous fibrosisOncol Rep20082051085109118949405
   PubMed Web of Science ®Google Scholar
• O’ConnorDSWallNRPorterACAltieriDCA p34(cdc2) survival checkpoint in cancerCancer Cell200221435412150824
   PubMed Web of Science ®Google Scholar
• YanHThomasJLiuTInduction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable survivin antagonistOncogene200625526968697416702945
   PubMed Web of Science ®Google Scholar
• PengXCYangLYangLPEfficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34–>Ala mutantJ Exp Clin Cancer Res2008274618816410
   PubMed Web of Science ®Google Scholar
• LiHXZhaoXYWangLAntitumor effect of mSurvivinThr34–>Ala in murine colon carcinoma when administered intravenouslyMed Oncol2009121 [Epub ahead of print]
   Web of Science ®Google Scholar
• McKayTRBellSTenevTProcaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategyOncogene200322233539354712789262
   PubMed Web of Science ®Google Scholar
• Blanc-BrudeOPMesriMWallNRPlesciaJDohiTAltieriDCTherapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesisClin Cancer Res2003972683269212855648
   PubMed Web of Science ®Google Scholar
• LiuTBrouhaBGrossmanDRapid induction of mitochondrial events and caspase-independent apoptosis in survivin-targeted melanoma cellsOncogene2004231394814712209
   PubMed Web of Science ®Google Scholar
• WangZFukudaSPelusLMSurvivin regulates the p53 tumor suppressor gene familyOncogene200423498146815315361831
   PubMed Web of Science ®Google Scholar
• ZhangMMukherjeeNBermudezRSAdenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivoProstate200564329330215754318
   PubMed Web of Science ®Google Scholar
• MaXZhengWWeiDConstruction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coliProtein Expr Purif2006471364416260148
   PubMed Web of Science ®Google Scholar
• ShenCLiuWBuckAKReskeSNPro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cellsAnticancer Res20092941423142819414397
   PubMed Web of Science ®Google Scholar
• ZhangRWangTLiKNA survivin double point mutant has potent inhibitory effect on the growth of hepatocellular cancer cellsCancer Biol Ther20087454755418296918
   PubMed Web of Science ®Google Scholar
• FukudaSPelusLMActivated H-Ras regulates hematopoietic cell survival by modulating survivinBiochem Biophys Res Commun2004323263664415369798
   PubMed Web of Science ®Google Scholar
• YuDDWangCTShiHSEnhancement of cisplatin sensitivity in lewis lung carcinoma by liposome-mediated delivery of a survivin mutantJ Exp Clin Cancer Res2010294620462440
   PubMed Web of Science ®Google Scholar
• XiaoWChenXYangLMaoYWeiYChenLCo-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposomeInt J Pharm20103931–211912620416367
   PubMed Web of Science ®Google Scholar
• GrossmanDKimPJSchechnerJSAltieriDCInhibition of melanoma tumor growth in vivo by survivin targetingProc Natl Acad Sci U S A200198263564011149963
   PubMed Web of Science ®Google Scholar
• DohiTOkadaKXiaFAn IAP-IAP complex inhibits apoptosisJ Biol Chem200427933340873409015218035
   PubMed Web of Science ®Google Scholar
• McNeishIALopesRBellSJSurvivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosisExp Cell Res20053021698215541727
   PubMed Web of Science ®Google Scholar
• OguraAWatanabeYIizukaDRadiation-induced apoptosis of tumor cells is facilitated by inhibition of the interaction between survivin and Smac/DIABLOCancer Lett20082591718117967504
   PubMed Web of Science ®Google Scholar
• BoyaPKroemerGLysosomal membrane permeabilization in cell deathOncogene200827506434645118955971
   PubMed Web of Science ®Google Scholar
• BarrettRMOsborneTPWheatleySPPhosphorylation of survivin at threonine 34 inhibits its mitotic function and enhances its cytoprotective activityCell Cycle20098227828319158485
   PubMed Web of Science ®Google Scholar
• KroemerGPouyssegurJTumor cell metabolism: cancer’s Achilles’ heelCancer Cell200813647248218538731
   PubMed Web of Science ®Google Scholar
• ShinSSungBJChoYSAn anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7Biochemistry20014041117112311170436
   PubMed Web of Science ®Google Scholar
• HaldarSNegriniMMonneMSabbioniSCroceCMDown-regulation of bcl-2 by p53 in breast cancer cellsCancer Res1994548209520978174112
   PubMed Web of Science ®Google Scholar
• StrobelTSwansonLKorsmeyerSCannistraSABAX enhances paclitaxel-induced apoptosis through a p53-independent pathwayProc Natl Acad Sci U S A1996932414094140998943066
   PubMed Web of Science ®Google Scholar
• AshcroftMVousdenKHRegulation of p53 stabilityOncogene199918537637764310618703
   PubMed Web of Science ®Google Scholar
• MarineJCLozanoGMdm2-mediated ubiquitylation: p53 and beyondCell Death Differ20101719310219498444
   PubMed Web of Science ®Google Scholar
• HoffmanWHBiadeSZilfouJTChenJMurphyMTranscriptional repression of the anti-apoptotic survivin gene by wild type p53J Biol Chem200227753247325711714700
   PubMed Web of Science ®Google Scholar
• IrwinMSKaelinWGp53 family update: p73 and p63 develop their own identitiesCell Growth Differ200112733734911457731
   PubMedGoogle Scholar
• YangAKaghadMCaputDMcKeonFOn the shoulders of giants: p63, p73 and the rise of p53Trends Genet2002182909511818141
   PubMed Web of Science ®Google Scholar
• YangAKaghadMWangYp63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activitiesMol Cell1998233053169774969
   PubMed Web of Science ®Google Scholar
• AltieriDCSurvivin, versatile modulation of cell division and apoptosis in cancerOncogene200322538581858914634620
   PubMed Web of Science ®Google Scholar
• AltieriDCThe case for survivin as a regulator of microtubule dynamics and cell-death decisionsCurr Opin Cell Biol200618660961516934447
   PubMed Web of Science ®Google Scholar
• LensSMRodriguezJAVaderGSpanSWGiacconeGMedemaRHUncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeresMol Biol Cell20061741897190916436504
   PubMed Web of Science ®Google Scholar
• RuchaudSCarmenaMEarnshawWCChromosomal passengers: conducting cell divisionNat Rev Mol Cell Biol200781079881217848966
   PubMed Web of Science ®Google Scholar
• ShanYWangCYangLInhibition of human lung adenocarcinoma growth using survivint34a by low-dose systematic administrationJ Biosci201035220921620689177
   PubMed Web of Science ®Google Scholar
• PanLPengXCLengFTherapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancerJ Cancer Res Clin Oncol201039 [Epub ahead of print]
   Web of Science ®Google Scholar
• O’ConnorDSSchechnerJSAdidaCControl of apoptosis during angiogenesis by survivin expression in endothelial cellsAm J Pathol2000156239339810666367
   PubMed Web of Science ®Google Scholar
• TranJRakJSheehanCMarked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cellsBiochem Biophys Res Commun1999264378178810544009
   PubMed Web of Science ®Google Scholar
• HarfoucheRHassessianHMGuoYMechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cellsMicrovasc Res200264113514712074640
   PubMed Web of Science ®Google Scholar
• PapapetropoulosAFultonDMahboubiKAngiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathwayJ Biol Chem2000275139102910510734041
   PubMed Web of Science ®Google Scholar
• MahboubiKLiFPlesciaJInterleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathwayLab Invest200181332733411310826
   PubMed Web of Science ®Google Scholar
• ZhangMCoenJJSuzukiYSurvivin is a potential mediator of prostate cancer metastasisInt J Radiat Oncol Biol Phys20107841095110320231071
   PubMed Web of Science ®Google Scholar
• MeliefCJCancer immunotherapy by dendritic cellsImmunity200829337238318799145
   PubMed Web of Science ®Google Scholar
• ChakravartiAZhaiGGZhangMSurvivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanismsOncogene200423457494750615326475
   PubMed Web of Science ®Google Scholar
• ZhangMLathamDEDelaneyMAChakravartiASurvivin mediates resistance to antiandrogen therapy in prostate cancerOncogene200524152474248215735703
   PubMed Web of Science ®Google Scholar
• FujieYYamamotoHNganCYOxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cellsJpn J Clin Oncol200535845346316024531
   PubMed Web of Science ®Google Scholar
• FerrarioARuckerNWongSLunaMGomerCJSurvivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment responseCancer Res200767104989499517510430
   PubMed Web of Science ®Google Scholar
• YuanQZWangCTMaoYQEnhanced tumor radiosensitivity by a survivin dominant-negative mutantOncol Rep20102319710319956869
   PubMed Web of Science ®Google Scholar
• CanovasPMGuadagnoTMFunctional analysis of survivin in spindle assembly in Xenopus egg extractsJ Cell Biochem2007100121722916888809
   PubMed Web of Science ®Google Scholar